Medical Condition News

RSS

Metabolic cell death pathways could be novel therapeutic targets in cancer treatment

The review discusses how metabolic cell death, distinct from traditional forms of regulated cell death like apoptosis, arises from imbalances in cellular metabolism due to nutrient and metal overload or depletion.

28 May 2024

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

NSCLC is the leading cause of cancer deaths globally, with EGFR mutations being a common feature in these cancers.

28 May 2024

Higher BMI linked to increased risk of binge-eating disorder in adolescents

A recent study in Appetite found that higher BMI is associated with an increased risk of progressing from binge-eating behavior to binge-eating disorder among U.S. adolescents. The findings emphasize the importance of early screening and intervention.

28 May 2024

Apple Hearing Study sheds light on tinnitus demographics and health impacts

About 78% of participants in the Apple Hearing Study, conducted by the University of Michigan, have experienced tinnitus—the perception of sound that others do not hear.

28 May 2024

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

A recent study in Nature Medicine found that LM11A-31, targeting the p75 neurotrophin receptor, is safe and shows promise in slowing Alzheimer's disease progression. The trial indicated significant biomarker improvements and potential benefits for further clinical investigation.

28 May 2024

Reducing cancer treatment frequency could cut greenhouse gas emissions

Changing how often a popular cancer therapy is delivered would reduce greenhouse gas emissions and improve environmental impact without decreasing cancer survival, according to a new analysis from researchers at the University of Michigan Health Rogel Cancer Center.

28 May 2024

The prediabetes paradox: Balancing early intervention and overdiagnosis

Prediabetes, a diagnosis intended to identify high-risk persons and prevent progression to diabetes, has been a topic of ongoing debate, and experts continue to disagree about its screening criteria, interpretation, and implications.

28 May 2024

Tattoos linked to higher risk of malignant lymphoma, study finds

A recent study in eClinicalMedicine links tattoo ink exposure to a 21% higher risk of malignant lymphoma, particularly B-cell subtypes. Tattoo ink and laser removal may play significant roles in lymphoma development.

28 May 2024

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

A recent study in Nature Medicine shows semaglutide reduces kidney risks in non-diabetic obese patients with cardiovascular disease by 22%. The SELECT trial results highlight semaglutide's benefits for kidney function and overall cardiovascular health.

28 May 2024

MUSC researchers unravel the mystery of cancer recurrence

MUSC Hollings Cancer Center researchers have unlocked a discovery that could help to explain why cancer can recur in patients who have undergone chemotherapy or radiotherapy.

28 May 2024

Silibinin: An old molecule with new promise in cancer treatment

A new review paper was published in Oncotarget's Volume 15 on May 23, 2024, entitled, "The importance of integrated therapies on cancer: Silibinin, an old and new molecule."

28 May 2024

Exercise pattern study reveals lower Parkinson's risk for weekend warriors and regulars alike

A recent study in npj Digital Medicine found that both "weekend warrior" and regular exercise patterns significantly reduce Parkinson's disease (PD) risk. The findings suggest exercise duration is more critical than frequency in mitigating PD risk.

28 May 2024

Light therapy may affect healing in the brains of people who suffered traumatic brain injury

Low-level light therapy appears to affect healing in the brains of people who suffered significant brain injuries, according to a study published today in Radiology, a journal of the Radiological Society of North America.

28 May 2024

Underappreciated set of enzymes connected to the regulation of hippo pathway in cancer

Within the family of cell membrane lipids known as phosphoinositides and the kinase enzymes that regulate them, phosphoinositide 3-kinases (PI3Ks) have been cast in a starring role as scientists study their involvement in cancer, diabetes and many cellular activities.

28 May 2024

New paper reveals the broad potential of TNIK as a therapeutic target for some aging-related diseases

A new paper in Trends in Pharmacological Sciences from researchers at generative artificial intelligence (AI)- and robotics-powered clinical stage drug discovery company Insilico Medicine ("Insilico") and ETH Zurich reveals the broad potential of TNIK as a therapeutic target for some of the most pervasive aging-related diseases, including fibrosis, cancer, obesity, and Alzheimer's.

28 May 2024

Novel coating in antipsychotics mitigates unwanted weight gain and boosts serotonin levels

Thousands of Australians struggle with serious mental health conditions. But when the recommended treatment involves antipsychotic medications, the side effects are excess kilos, which only adds weight to an already complex diagnosis.

28 May 2024

Understanding the link between EBV-infected B cells and multiple sclerosis

The Wistar Institute's Paul M. Lieberman, Ph.D., and lab team led by senior staff scientist and first author, Samantha Soldan, Ph.D., have demonstrated how B cells infected with the Epstein-Barr virus (EBV) can contribute to a pathogenic, inflammatory phenotype that contributes to multiple sclerosis (MS); the group has also shown how these problematic B cells can be selectively targeted in a way that reduces the damaging autoimmune response of multiple sclerosis.

28 May 2024

Study reveals pivotal role of the circadian clock in enhancing checkpoint inhibitor cancer therapy

A multidisciplinary research team at the University of California, Irvine has revealed that the circadian clock – the biological pacemaker that governs daily rhythms in physiological processes, including immune functions – can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy.

28 May 2024

Discovery of promising protein candidate opens new avenues for treating metabolic disorders

A University of Saskatchewan (USask) research team's discovery of the additional health benefits of an appetite-suppressing protein has doubled the potential for scientists to find new avenues for treating obesity and metabolic disorders in animals and people.

28 May 2024

New subset of T cells may enhance cancer immunotherapy

A team of cancer researchers, led by the University of Houston, has discovered a new subset of T cells that may improve the outcome for patients treated with T-cell therapies.

28 May 2024

Medical Condition News

Metabolic cell death pathways could be novel therapeutic targets in cancer treatment

Targeting CD47 to improve osimertinib efficacy in EGFR mutant NSCLC

Higher BMI linked to increased risk of binge-eating disorder in adolescents

Apple Hearing Study sheds light on tinnitus demographics and health impacts

New Alzheimer's drug LM11A-31 shows promise in slowing disease progression in clinical trial

Reducing cancer treatment frequency could cut greenhouse gas emissions

The prediabetes paradox: Balancing early intervention and overdiagnosis

Tattoos linked to higher risk of malignant lymphoma, study finds

Semaglutide shows significant kidney benefits in non-diabetic obese patients with heart disease

MUSC researchers unravel the mystery of cancer recurrence

Silibinin: An old molecule with new promise in cancer treatment

Exercise pattern study reveals lower Parkinson's risk for weekend warriors and regulars alike

Light therapy may affect healing in the brains of people who suffered traumatic brain injury

Underappreciated set of enzymes connected to the regulation of hippo pathway in cancer

New paper reveals the broad potential of TNIK as a therapeutic target for some aging-related diseases

Novel coating in antipsychotics mitigates unwanted weight gain and boosts serotonin levels

Understanding the link between EBV-infected B cells and multiple sclerosis

Study reveals pivotal role of the circadian clock in enhancing checkpoint inhibitor cancer therapy

Discovery of promising protein candidate opens new avenues for treating metabolic disorders

New subset of T cells may enhance cancer immunotherapy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News